Searched for
GST CUT IN PHARMA
Markets overlooking macro stress, says Kunal Vora amid oil and currency shockDespite a calm surface, Indian equity markets face mounting macroeconomic pressures from rising crude oil prices and a weakening rupee. Exp...- Why smallcap funds are still a buy: A long-term strategy from Aditya KhemaniSmallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- FY27 Outlook: Geopolitical pressure and AI disruption set to reshape India IncCorporate India faces heightened uncertainty entering fiscal year 2026-27 due to geopolitical tensions and AI disruption. Sectors like bank...
- Limited impact of tariff on pharma, IT under pressure; IPOs & defence in focus: Shreyash DevalkarShreyash Devalkar of Axis Mutual Fund advises careful investment. Pharma faces neutral impact from US tariffs. IT sector experiences global...
- SBI Card likely to benefit from festival season and GST cuts: Amnish AggarwalIndian markets are currently experiencing significant activity across various sectors. Pharma companies like Glenmark, Dr Reddy's, and Lupi...
- "Transformative shift in India's healthcare": Pharma alliance lauds GST reforms ahead of implementationThe Indian Pharmaceutical Alliance lauds the upcoming GST reforms, effective Monday, as a transformative step towards affordable healthcare...
- Markets likely to stay range-bound in near term, gain momentum in H2: Mahesh PatilIndian equities may remain range-bound in the near term but are set to pick up momentum in the second half of the fiscal, driven by earning...
- GST relief: Companies asked to share revised prices of consumer durables, cars with consumersThe central government directs businesses to submit tentative price lists following the Goods and Services Tax reduction. These lists, cove...
- Markets cheer as Trump-Modi trade talk optimism boosts sentimentUS and India trade talks show promise. Donald Trump and Narendra Modi are highlighting progress. A deal may finalize by November. Market ex...
- More patients can access key drugs after GST rate cutsRecent GST rate cuts on critical medicines are set to significantly reduce costs for treatments of conditions like multiple myeloma, lung c...
- Abhay Agarwal identifies 4 sectors as next growth drivers, with India turning tariff threats into reform opportunityAbhay Agarwal, Founder of Piper Serica Advisors, said India is converting global tariff uncertainty into reform-driven growth. He sees four...
- Stocks in news: Hyundai India, Vedanta, Adani Power, Tata Motors, Aurobindo PharmaIndian markets remained mostly stable on Friday, with several companies making headlines. Hyundai India will reduce prices following GST re...
- Crucial drugs to be more affordable after GST cutThe government has significantly reduced GST rates on 41 highly priced medicines, including those for cancer, rare diseases, and heart cond...
- Markets pin hopes on GST meet as cyclical revival gains traction: Varun GoelAs the GST Council convenes, investors anticipate announcements that could influence market sentiment. Expert Varun Goel predicts FY26 as a...
- FMCG in a sweet spot after GST cuts and monsoon boost: Rajat SharmaMarkets are positive due to GST bonanza. Rajat Sharma of Sana Securities highlights FMCG's sweet spot, driven by revised tax rates and good...
- Pricing strategies of 50 companies under NAA lensNational Anti-profiteering Authority (NAA) has issued letters to various companies including Mankind Pharma, Johnson & Johnson, Nirma and C...
- GST euphoria gone: Market at a critical juncture; tread carefullyTraders should enter longs only if the upper resistance of 9,720 is surpassed decisively.
- GST bill bigger near-term factor for markets than P-Notes: Avinnash Gorakssakar, Precision Investment"This could be a big negative surprise if nothing materialises by the end of the session. It could be a key factor for markets."
Load More
